Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
12/2003
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/11/2003US20030229050 Insecticidal anthranilamides
12/11/2003US20030228982 Substituted phenyl derivatives
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/11/2003CA2487475A1 Method of forming a carbon-carbon or carbon-heteroatom linkage
12/11/2003CA2485871A1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/10/2003EP1368308A1 Cannabinoid receptor ligands
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003CN1130348C Pyrazole formanilide fungicide
12/10/2003CN1130124C Fungicidal mixtures
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660732 Ureas and thioureas inhibit production of cytokines
12/09/2003US6660465 Yellow coupler and silver halide color photographic lightsensitive material containing the same
12/09/2003US6660046 Cationic oxidation bases, their use of dyeing keratin fibres, dyeing compositions and dyeing methods
12/04/2003WO2003099794A1 Synthesis of diaryl pyrazoles
12/04/2003WO2003099793A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/04/2003WO2003099221A2 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003WO2003098992A2 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225151 Pyrazole compositions useful as inhibitors of ERK
12/04/2003US20030225089 Pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225084 Have an affinity for the gabapentin binding site and can be used to treat conditions such as pain, epilepsy, migraine and others.
12/04/2003US20030225077 Naphthylamines used to chronic inflammatory diseases.
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225070 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/04/2003US20030224941 Uracil substituted phenyl sulfamoyl carboxamides
12/04/2003US20030224442 Comprises nucleotide sequences coding g-protein coupled receptor for use in treatment of anxiety, depression, obsessive-compulsive, schizophrenia autism, migraine, emesis, alcoholism and neurodegenerative disorders
12/04/2003CA2487401A1 Synthesis of diaryl pyrazoles
12/04/2003CA2487315A1 1,2-azole derivatives with hypoglycemic and hypolipidemic activity
12/04/2003CA2487073A1 Methods for using jnk inhibitors for treating or preventing disease-related wasting
12/04/2003CA2486376A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
12/03/2003EP1366045A2 Efficient process for the preparation of a factor xa inhibitor
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
12/03/2003CN1460097A NF-kB inhibitor containing substituted benzoic acid derivative as active ingredient
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656941 Altering the signal-transducing activity of GABAA receptors; diagnosis and treatment of anxiety, depression, Down Syndrome, sleep and seizure disorders
12/02/2003US6656933 Novel compounds which inhibit production of cytokines involved in inflammatory processes
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
11/2003
11/27/2003WO2003097610A1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/27/2003WO2003097609A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/27/2003CA2486097A1 N-substituted tricyclic 3-aminopyrazoles as pdfg receptor inhibitors
11/26/2003EP1364212A2 Three hybrid assay system
11/26/2003EP1363889A1 Novel diaminopyrazole derivatives and their use for oxidation dyeing of keratinous fibres
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP1363638A2 Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
11/26/2003EP0673937B1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653086 Fusion protein; ligand has not been identified; screening for agonists/ antagonists
11/20/2003WO2003095563A1 Trisazo dyes for ink jet printing
11/20/2003WO2003095562A1 Trisazo dyes for ink jet printing
11/20/2003WO2003095430A1 Substituted pyrazolyl compounds for the treatment of inflammation
11/20/2003WO2003095429A1 Active substances for the treatment, diagnosis and prophylaxis of diseases in which abnormal protein structures occur
11/20/2003WO2003094854A2 Succinoyl aminopyrazoles and related compounds
11/20/2003WO2003087062A3 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
11/20/2003US20030216434 Cyclic derivatives as modulators of chemokine receptor activity
11/20/2003US20030216394 Etylene derivatives and pesticides containing said derivatives
11/19/2003EP1362852A1 Pyrazole derivative, intermediate therefor, processes for producing these, and herbicide containing these as active ingredient
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1362049A1 Novel pyrazolo-triazoles and use of said compounds for dyeing keratinous fibres
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362037A1 Process for synthesis of heteroaryl-substituted urea compounds useful as antiinflammatory agents
11/19/2003EP1362036A1 Diaminopyrazole compounds and the use thereof in the oxidation dyeing of keratinous fibres
11/19/2003EP1362035A1 Diaminopyrazole compounds and the use thereof in the oxidation dyeing of keratinous fibres
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003CN1456154A Method for curing sepsis
11/18/2003US6649645 Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
11/18/2003US6649638 Prenylation inhibitors and methods of their synthesis and use
11/18/2003US6649629 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003093246A1 Ionic liquids
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003092679A1 Preparation of phosphatase inhibitors
11/13/2003WO2003051906A3 Compounds and methods
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2002083622A3 Novel aminophenyl ketone derivatives
11/13/2003WO2002055486A3 Triazene compounds and use thereof
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212121 Antiproliferative agents; anticancer agents; autoimmune diseases; cardiovascular disorders
11/13/2003US20030212117 Efficient process for the preparation of a factor Xa inhibitor
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003CA2483829A1 Ionic liquids
11/13/2003CA2462645A1 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/12/2003EP1360901A1 2,3-cyclic substituted derivatives of 3-hydroxyacrolein and 3-hydroxyacrylic acid as pesticides
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1209975B1 Herbicidal composition
11/12/2003EP1115707B1 Benzamide derivatives and ther use as cytokine inhibitors
11/12/2003CN1127485C Fluoropyrazole-biphenylamide fungicides
11/12/2003CN1127484C Substituted pyrazolyl benzene sulfone amides compounds for curing inflammation
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 256